Skip to content
bluejethealthcare.com
About Us
Company Overview
Our Journey
Board of Directors
News and Media
Business Segments
Contrast Media Intermediates
Artificial Sweetners
Protected Amino Acid & Derivatives
CDMO-Pharma Intermediates & APIs
Capabilities
R & D Capabilities
Reaction Capabilities
Manufacturing Capabilities
EHS
Investor Relations
Notices
Investor Presentation
Dividend Details
Stock Exchange Communication
Financial Information
Annual Return
Annual Report
Corporate Governance
Board Committees
Governance Policies
Related Party Transactions
Prospectus / MOA / AOA
Investors Contact
Regulation 46 SEBI LODR
Shareholding Pattern
AGM / EGM
Credit Rating
Annual Secretarial Compliance Report
Prospectus
Contact Us
About Us
Company Overview
Our Journey
Board of Directors
News and Media
Business Segments
Contrast Media Intermediates
Artificial Sweetners
Protected Amino Acid & Derivatives
CDMO-Pharma Intermediates & APIs
Capabilities
R & D Capabilities
Reaction Capabilities
Manufacturing Capabilities
EHS
Investor Relations
Notices
Investor Presentation
Dividend Details
Stock Exchange Communication
Financial Information
Annual Return
Annual Report
Corporate Governance
Board Committees
Governance Policies
Related Party Transactions
Prospectus / MOA / AOA
Investors Contact
Regulation 46 SEBI LODR
Shareholding Pattern
AGM / EGM
Credit Rating
Annual Secretarial Compliance Report
Prospectus
Contact Us
Financial Year 2024-25
Quarterly Results
Financials June 2024
Financials September 2023
Financial Year 2023-24
BRSR- 2023-24
Annual Report 2023-24
Quarterly Results
Financials March 2024
Financials December 2023
Financials September 2023
Financials June 2023
Financial Year 2022-23
Standalone Annual Report FY 22-23
Financial Year 2021-22
Standalone Annual Report FY 21-22
Financial Year 2020-21
Consolidated Annual Report FY 20-21
Standalone Annual Report FY 20-21
Scroll to Top
